COEP
Coeptis Therapeutics Inc
NASDAQ: COEP · HEALTHCARE · BIOTECHNOLOGY
$16.40
+1.17% today
Updated 2026-04-24
Market cap
$102.06M
P/E ratio
—
P/S ratio
74.88x
EPS (TTM)
$-2.81
Dividend yield
—
52W range
$7 – $21
Volume
0.0M
WallStSmart proprietary scores
23
out of 100
Grade: F
Strong Sell
Investment rating
6.3
Growth
B5.0
Quality
C+2.5
Profitability
F6.7
Valuation
B—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
$3.00
-81.71%
12-Month target
—
—
Intrinsic (DCF)
$57.26
Margin of safety
+79.06%
Price chart
X-Ray snapshot
Strengths
+ Revenue growth 1,564.00% QoQ
+ 79.06% below intrinsic value
Risks
- Thin margins at 0.00%
- Negative free cash flow $-1.69M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $1.36M | $1.36M |
| Net income | $-37.57M | $-21.27M | $-10.88M | $-11.92M | $-1.58M |
| EPS | — | — | — | — | $-2.81 |
| Free cash flow | $-3.88M | $-3.88M | $-6.65M | $-8.60M | $-1.69M |
| Profit margin | — | — | — | -874.29% | — |
Peer comparison
Smart narrative
Coeptis Therapeutics Inc trades at $16.40. Our Smart Value Score of 23/100 indicates the stock is weak. TTM revenue stands at $1.36M. Our DCF model estimates intrinsic value at $57.26.
Frequently asked questions
What is Coeptis Therapeutics Inc's stock price?
Coeptis Therapeutics Inc (COEP) trades at $16.40.
Is Coeptis Therapeutics Inc overvalued?
Smart Value Score 23/100 (Grade F, Strong Sell). DCF value $57.26.
What is the price target of Coeptis Therapeutics Inc (COEP)?
The analyst target price is $3.00, representing -81.7% downside from the current price of $16.40.
What is the intrinsic value of Coeptis Therapeutics Inc (COEP)?
Based on our DCF model, intrinsic value is $57.26, a +79.1% margin of safety versus $16.40.
What is Coeptis Therapeutics Inc's revenue?
TTM revenue is $1.36M.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio74.88x
ROE-136.90%
Beta-0.43
50D MA$12.26
200D MA$13.58
Shares out0.01B
Float0.01B
Short ratio—
Avg volume0.0M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—